- Home
- / Algernon Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Algernon Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.1
2024-10-29
Market Capitalization
$2.2 M
2024-10-29
CreditSafe Score
?
Score changed on Jul 15, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating expense total | 908.0K | 1.9M | 7.5M | 7.4M | 5.1M | 6.2M | 2.4M | 1.7M |
| Depreciation and amortization | 40.0K | 49.0K | 35.0K | 50.0K | 27.0K | |||
| EBITDA | (908.0K) | (1.9M) | (7.5M) | (7.4M) | (5.1M) | (6.2M) | (2.4M) | (1.7M) |
| EBIT | (948.0K) | (1.9M) | (7.4M) | (7.1M) | (5.1M) | (6.3M) | (504.0K) | (1.7M) |
| Interest income | 11.0K | 6.0K | 35.0K | 12.0K | 2.0K | 2.0K | 1.0K | 1.0K |
| Pre tax profit | (937.0K) | (1.9M) | (8.5M) | (7.7M) | (6.1M) | (6.8M) | (503.0K) | (1.7M) |
| Net Income | (937.0K) | (1.9M) | (8.5M) | (7.7M) | (6.1M) | (6.8M) | (503.0K) | (1.7M) |